HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Zheng Miao Selected Research
Zheng Miao Research Topics
Disease
36
Neoplasms (Cancer)
09/2021 - 09/2009
7
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 11/2017
5
Melanoma (Melanoma, Malignant)
09/2013 - 10/2009
4
Neoplasm Metastasis (Metastasis)
01/2020 - 10/2009
3
Glioblastoma (Glioblastoma Multiforme)
02/2013 - 12/2009
2
Fibrosis (Cirrhosis)
12/2023 - 05/2023
2
Rectal Neoplasms (Rectal Cancer)
01/2022 - 01/2020
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2019 - 06/2012
2
Prostatic Neoplasms (Prostate Cancer)
09/2013 - 06/2012
2
Carcinoma (Carcinomatosis)
09/2013 - 06/2012
2
Breast Neoplasms (Breast Cancer)
07/2012 - 02/2012
1
Hypertrophy
12/2023
1
Heart Failure
12/2023
1
Diabetic Cardiomyopathies
05/2023
1
Chemical and Drug Induced Liver Injury
05/2023
1
Adrenocortical Carcinoma
05/2020
1
Endometrial Stromal Sarcoma
01/2020
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020
1
Pain (Aches)
08/2019
1
Germinoma
03/2019
1
Hypoxia (Hypoxemia)
11/2018
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2018
1
Hemorrhagic Fever with Renal Syndrome (HFRS)
10/2018
1
Huntington Disease (Huntington's Disease)
01/2018
1
Disease Progression
01/2018
1
Neuroinflammatory Diseases
01/2018
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2016
1
Stroke (Strokes)
12/2014
1
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2014
1
Ovarian Neoplasms (Ovarian Cancer)
11/2014
1
Adenocarcinoma
07/2013
1
Pancreatic Neoplasms (Pancreatic Cancer)
07/2013
Drug/Important Bio-Agent (IBA)
15
Peptides (Polypeptides)
IBA
11/2014 - 11/2009
11
Integrins
IBA
11/2014 - 12/2009
7
Proteins (Proteins, Gene)
FDA Link
07/2012 - 09/2009
7
ErbB Receptors (EGF Receptor)
IBA
07/2012 - 05/2010
6
Cystine-Knot Miniproteins
IBA
11/2014 - 12/2009
6
Molecular Probes (Molecular Probe)
IBA
09/2013 - 09/2009
6
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
IBA
07/2012 - 03/2010
4
Biomarkers (Surrogate Marker)
IBA
01/2018 - 09/2009
4
Cystine (L-Cystine)
IBA
11/2014 - 02/2010
3
Coloring Agents (Dyes)
IBA
11/2014 - 05/2010
3
Metals
IBA
11/2014 - 11/2009
3
Agouti-Related Protein
IBA
02/2013 - 02/2010
3
Radioisotopes (Radionuclides)
IBA
07/2012 - 04/2011
3
CY5.5 cyanine dye
IBA
06/2012 - 03/2010
3
Peptidomimetics
IBA
01/2012 - 12/2009
2
Radiopharmaceuticals
IBA
01/2016 - 06/2012
2
Chelating Agents
IBA
11/2014 - 06/2011
2
Melanins (Melanin)
IBA
09/2013 - 10/2009
2
Bombesin Receptors (Bombesin Receptor)
IBA
09/2013 - 06/2012
2
Bombesin
IBA
09/2013 - 06/2012
2
Indicators and Reagents (Reagents)
IBA
11/2011 - 05/2010
2
Rhenium
IBA
12/2010 - 11/2009
2
Trypsin Inhibitors
IBA
03/2010 - 12/2009
1
Long Noncoding RNA
IBA
12/2023
1
Blood Glucose (Blood Sugar)
IBA
05/2023
1
Streptozocin (Streptozotocin)
FDA Link
05/2023
1
rubiadin
IBA
05/2023
1
Phosphotransferases (Kinase)
IBA
09/2021
1
squamous cell carcinoma-related antigen
IBA
11/2019
1
Etanidazole
IBA
11/2018
1
carbogen
IBA
11/2018
1
Nitroimidazoles
IBA
11/2018
1
Flame Retardants (Fire Retardants)
IBA
10/2018
1
Halogenated Diphenyl Ethers
IBA
10/2018
1
dechlorane plus
IBA
10/2018
1
LM11A-31
IBA
01/2018
1
Ligands
IBA
01/2018
1
acetamide
IBA
01/2015
1
Minocycline (Cyclops)
FDA Link
Generic
12/2014
1
Dendrimers (Dendrons)
IBA
11/2014
1
4-nitrophenyl
IBA
11/2014
1
N,N-diethylethylenediamine
IBA
09/2013
1
pyridine
IBA
09/2013
1
benzamide
IBA
09/2013
1
Niacinamide (Nicotinamide)
FDA Link
Generic
09/2013
1
Benzene (Benzole)
IBA
09/2013
1
arginyl-glycyl-aspartic acid
IBA
09/2013
1
Cell Surface Receptors
IBA
07/2013
1
picolinamide
IBA
02/2013
1
polypeptide C
IBA
02/2013
1
Cys-ZHER2-342 affibody
IBA
07/2012
1
Fluorescent Dyes (Fluorescent Probes)
IBA
06/2012
1
Tumor Biomarkers (Tumor Markers)
IBA
06/2012
1
Ethylene Glycol (Monoethylene Glycol)
IBA
06/2012
Therapy/Procedure
12
Radiotherapy
01/2022 - 01/2015
10
Therapeutics
01/2022 - 09/2009
3
Drug Therapy (Chemotherapy)
01/2022 - 11/2017
3
Brachytherapy
01/2021 - 11/2017
3
Chemoradiotherapy
12/2019 - 11/2018
2
Neoadjuvant Therapy
01/2022 - 01/2020
2
Adjuvant Radiotherapy
05/2020 - 01/2020
2
Aftercare (After-Treatment)
11/2018 - 01/2015
1
Adjuvant Chemotherapy
01/2022
1
Surgical Instruments (Clip)
01/2021
1
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2020
1
Craniospinal Irradiation
03/2019
1
Duration of Therapy
11/2018
1
Oral Administration
01/2018